“You may choose to look the other way, but you can never say again that you did not know.”
— William Wilberforce
The U.S. Department of Health and Human Services (HHS) has announced that the agency is amending an emergency declaration under the Public Readiness and Emergency Preparedness Act (PREP Act) to authorize additional medical professionals to administer experimental COVID-19 vaccines being distributed under an Emergency Use Authorization (EUA).1 2 This announcement was made after President Biden […]
A highly-rated nonprofit vaccine safety charity has been censored by Facebook on behalf of pharmaceutical industry interests in a purge of vaccine safety information. The National Vaccine Information Center (NVIC) had maintained a Facebook page since 2008. The organization was started 39-years ago. Co-founder and president is Barbara Loe Fisher. Fisher became a vaccine safety advocate after her […]
Opinion | The experimental COVID-19 vaccines are being released first to a designated group of health care workers and residents of senior living facilities. As more of the vaccines becomes available, people at high-risk to the SARS-CoV-2 virus due to their medical conditions will be given an opportunity to get vaccines. Finally, the general public […]
Between Dec. 11 and 18, 2020, the U.S. Food and Drug Administration (FDA) granted Pfizer/BioNTech and Moderna pharmaceutical companies an Emergency Use Authorization (EUA)1 to distribute COVID-19 vaccines using messenger RNA (mRNA) technology that to date has not been licensed for use in humans.2 3 4 5 Although the Advisory Committee on Immunization Practices (ACIP) […]
In July 2020, the U.S. Department of Health and Human Services (HHS) published a notice of proposed rule making in the Federal Register1 that would remove shoulder injuries and vasovagal syncope from the Vaccine Injury Table used by the National Vaccine Injury Compensation Program (NVICP). The proposed rule making would also eliminate Item XVII, whereby […]
The U.S. National Institutes of Health (NIH) has provided the University of Maryland with a $3.5 million dollar grant to develop a vaccine for Lyme disease.1 Principal investigators Utal Pal, PhD, professor at the Virginia-Maryland College of Veterinary Medicine at the University of Maryland College of Agriculture and Natural Resources and Matthias Schnell, PhD, director […]
Biopharmaceutical company CureVac NV of Tübingen, Germany has released the interim results of its Phase 1 clinical trial on its experimental CVnCoV vaccine COVID-19. The vaccine, which was given to more than 250 healthy adults 18 to 60 years of age, is based on messenger ribonucleic acid (mRNA) technology.1 2 Unlike traditional vaccines, mRNA vaccines […]
Biotechnology firm Moderna, Inc. of Cambridge, Massachusetts began a Phase 3 human clinical trial to test the safety and efficacy of its experimental mRNA-1273 COVID-19 vaccine on July 27, 2020. The randomized, placebo-controlled trial involves giving two 100-microgram doses of the vaccine to 28,618 volunteer participants over 18 years of age, including some elderly people […]
On Oct. 14, 2020, Pfizer, Inc. of New York City, New York announced it had received approval by the U.S. Food and Drug Administration (FDA) to enroll children in the Phase 3 human clinical trial on its experimental messenger RNA (ribonucleic acid) BNT162b1 vaccine for COVID-19. The trial, which last month was expanded to include adolescent […]
The American Academy of Pediatrics (AAP) is asking federal officials to include children in COVID-19 vaccine trials.1 On September 29, 2020, Sara Goza, MD, president of the AAP, wrote a letter addressed to U.S. Department of Health and Human Services (HHS) Secretary Alex Azar and Food and Drug Administration (FDA) Commissioner Steven Hahn, MD stating, […]